# Scion Cardio-Vascular, Inc.

- Location (FDA's records): Miami, FL
- FDA decisions: 4 (2004–2011): 4 510(k) clearances
- Product codes: QSY (3), HCG (1)
- Predicates its devices cite: 6 (1 its own); citations of its devices by later devices: 11 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Advanced Medical Solutions Limited: 1 (https://510kreport.com/company/advanced-medical-solutions)
- Abbott Vascular: 1 (https://510kreport.com/company/abbott-vascular)
- T-Scientific, Inc.: 1 (https://510kreport.com/company/t-scientific)
- Marine Polymer Technologies, Inc.: 1 (https://510kreport.com/company/marine-polymer-technologies)
- Boston Scientific Corp: 1 (https://510kreport.com/company/boston-scientific)

## Firms that cite its devices most
- Hem Con Medical Technologies, Inc.: 4 (https://510kreport.com/company/hem-con-medical-technologies)
- Bionova Medical, Inc.: 1 (https://510kreport.com/company/bionova-medical)
- Coreleader Biotech Co., Ltd.: 1 (https://510kreport.com/company/coreleader-biotech)
- Benq Materials Corporation: 1 (https://510kreport.com/company/benq-materials)
- Chitogen, Inc.: 1 (https://510kreport.com/company/chitogen)
- Innotherapy, Inc.: 1 (https://510kreport.com/company/innotherapy)
- Medtrade Products, Ltd.: 1 (https://510kreport.com/company/medtrade-products)

## Its most-cited devices
- K032986: Clo-Surplusp.a.D. (2004), cited by 7
- K092552: Clo-Surplus P.a.D. (2009), cited by 3
- K112961: Clo-Surplus P.a.D. (2011), cited by 1

## Recent decisions
- K112961: Clo-Surplus P.a.D. (Oct 31, 2011)
- K092552: Clo-Surplus P.a.D. (Sep 4, 2009)
- K052509: M-Bolus Embolic Microspheres (Dec 11, 2006)
- K032986: Clo-Surplusp.a.D. (Mar 1, 2004)

Source page: https://510kreport.com/company/scion-cardio-vascular